From June 7, 2022 to July 6, 2022, the company has repurchased 39,777 shares, representing 0.66% for KRW 4,574.17 million. With this, the company has completed the repurchase of 39,777 shares, representing 0.66% for KRW 4,574.17 million under the buyback announced on June 7, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
129,000 KRW | -0.77% | -4.80% | -46.47% |
03-21 | Medy-Tox Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-05 | South Korean Shares Close Marginally Lower on North Korea's Artillery Shells Firing | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-46.47% | 636M | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-15.02% | 32.79B | |
+64.13% | 26.23B | |
-21.88% | 14.52B | |
-7.65% | 13.09B | |
-42.60% | 11.6B | |
-12.64% | 11.5B | |
+4.94% | 8.82B |
- Stock Market
- Equities
- A086900 Stock
- News Medy-Tox Inc.
- Tranche Update on Medy-Tox Inc.'s Equity Buyback Plan announced on June 7, 2022.